Mainz Biomed B.V.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Mainz Biomed B.V.'s past years’ income statements indicate that its last revenue has increased compared to the previous period by 69% to $895,479. The net income raised on -$26,295,727 and profit margin reached -2936%. Total operating expenses were $27,154,341.

Profit Margin

Mainz Biomed B.V. (NASDAQ:MYNZ): Profit margin
2019 281.39K -1.17M -417.48%
2020 493.56K -886.17K -179.55%
2021 577.34K -12.07M -2090.99%
2022 529.87K -26.45M -4992.24%
2023 895.47K -26.29M -2936.5%

MYNZ Income Statement (2019 – 2023)

2023 2022 2021 2020 2019
Revenue
Revenue
895.47K529.87K577.34K493.56K281.39K
Cost of revenue
385.82K347.72K399.72K370.48K342.66K
Gross profit
509.65K182.15K177.62K123.08K-61.27K
Operating exp.
Research and development
9.59M3.66M466.68K311.85K250.31K
Selling and marketing
3.80M4.97M957.52K110.38K181.46K
Total operating expenses
27.15M26.35M9.55M479.38K690.21K
Operating income
-26.64M-26.17M-9.37M-325.81K-921.90K
Other income (expenses), net
348.95K-212.58K-2.31M-261.08K-35.14K
Income before tax
-26.29M-26.38M-11.69M-586.89K-957.05K
Income tax expense
065.38K377.12K299.28K217.71K
Net income
-26.29M-26.45M-12.07M-886.17K-1.17M
Earnings per share
Basic EPS
-1.62-1.87-1.67-0.16-0.1
Diluted EPS
-1.62-1.87-1.67-0.16-0.1
Data sourceData sourceData source